Given the absence of established guidelines for the optimal duration and discontinuation of TXA in perinatal stroke associated with PAI-1 deficiency, we propose a genotype-guided approach to therapy. This evidence concerns the gene SERPINE1 and hyperinsulinemic hypoglycemia, familial, 4.